|
1999 Conference Publication Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.Ramm, G.A., Murphy, T.L., Fanning, P.A., Clouston, A.D., Anderson, G.J. and Crawford, D.H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.. 50th Annual Meeting American Association for the Study of Liver Disease, Dallas, TX, United States, 5-9 November 1999. Hoboken, NJ, United States: John Wiley & Sons. |
|
1999 Conference Publication Identification and characterisation of a receptor for transferrin on hepatic stellate cells: role in the transformation to myofibroblastsBridle, K., Blanch, N. L., Crawford, D. H. and Ramm, G. A. (1999). Identification and characterisation of a receptor for transferrin on hepatic stellate cells: role in the transformation to myofibroblasts. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 Oct, 1999. Carlton, Vic: Blackwell Science Asia. |
|
1999 Conference Publication Hepatic stellate cells are responsible for increased type I collagen production leading to cirrhosis in cystic fibrosis liver diseaseBlanch, N. L., Greco, S., Lewindon, P., Ramm, G. A., Shepherd, R. W., Smith, J. L. and Walker, N. I. (1999). Hepatic stellate cells are responsible for increased type I collagen production leading to cirrhosis in cystic fibrosis liver disease. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 October, 1999. Carlton, Vic: Blackwell Science. |
|
1999 Conference Publication Hepatic iron overload in pathogen-free gerbils does not result in bridging fibrosis or cirrhosisRamm, G. A., Britton, R. S., Brunt, E. M., O'Neil, R. and Bacon, B. R. (1999). Hepatic iron overload in pathogen-free gerbils does not result in bridging fibrosis or cirrhosis. Bioiron'99, Sorrento Palace, Sorrento - Naples, Italy, 23 - 28 May 1999. Italy: SGC. |
|
1999 Journal Article HaemochromatosisCrawford, D. H. G. and RammGA (1999). Haemochromatosis. Trends in Endocrinology and Metabolism, 10 (1), 14-17. doi: 10.1016/S1043-2760(98)00103-9 |
|
1999 Conference Publication Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseasesRamm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 October,1999. Carlton, Vic: Blackwell Science Asia. |
|
1999 Conference Publication Evaluation of serum TIMP-1 collagen type IV and MMP-2 as markers of hepatic fibrogenesis in cystic fibrosis liverLewindon, P., Murphy, T. M., Pereira, T., Ramm, G. A., Shepherd, R. W. and Smith, J. L. (1999). Evaluation of serum TIMP-1 collagen type IV and MMP-2 as markers of hepatic fibrogenesis in cystic fibrosis liver. Australian Gastroenterology Week 1999, Brisbane, Australia, 4-8 October 1999. Carlton, Vic: Blackwell Science. |
|
1999 Conference Publication Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseasesRamm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. American Assoc. for the Study of Liver Diseases 50th Annual Meeting, Dallas, Texas, USA, 5 - 9 Nov, 1999. USA: W B Saunders Co.. |
|
1998 Journal Article Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresiaRamm, G. A., Nair, V. G., Bridle, K. R., Shepherd, R. W. and Crawford, D. H. G. (1998). Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. American Journal of Pathology, 153 (2), 527-535. doi: 10.1016/S0002-9440(10)65595-2 |
|
1998 Journal Article Evidence for altered hepatic matrix degradation in genetic haemochromatosisGeorge, D.K., Ramm, G.A., Powell, L.W., Fletcher, L.M., Walker, N.I., Cowley, L.L. and Crawford, D.H.G. (1998). Evidence for altered hepatic matrix degradation in genetic haemochromatosis. Gut, 42 (5), 715-720. doi: 10.1136/gut.42.5.715 |
|
1998 Conference Publication The contribution of inflammatory cells to iron-induced hepatic fibrogenesis in hemochromatosisBridle, K. R., Crawford, D. H. G., Smith, J. L., Fletcher, L. M., Walker, N. I. and Ramm, G. A. (1998). The contribution of inflammatory cells to iron-induced hepatic fibrogenesis in hemochromatosis. 49th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 6-10 November 1998. Hoboken, NJ, United States: John Wiley & Sons. |
|
1998 Conference Publication Ferritin increases PKC-zeta expression in early rat hepatic stellate cell activationRamm, G.A., Coomer, J.M., Watters, D.J. and Crawford, D.H.G. (1998). Ferritin increases PKC-zeta expression in early rat hepatic stellate cell activation. 49th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 6-10 November 1998. Hoboken, NJ, United States: John Wiley & Sons. |
|
1997 Journal Article Excess iron induces hepatic oxidative stress and transforming growth factor beta 1 in genetic hemochromatosisHouglum, K., Ramm, G. A., Crawford, D. H. G., Witztum, J. L., Powell, L. W. and Chojkier, M. (1997). Excess iron induces hepatic oxidative stress and transforming growth factor beta 1 in genetic hemochromatosis. Hepatology, 26 (3), 605-610. doi: 10.1002/hep.510260311 |
|
1997 Journal Article Evidence that 'myofibroblast-like' cells are the cellular source of capsular collagen in hepatocellular carcinomaOoi, L. P. J., Crawford, D. H. G., Gotley, D. C., Clouston, A. D., Strong, R. W., Gobe, G. C., Halliday, J. W., Bridle, K. R. and Ramm, G. A. (1997). Evidence that 'myofibroblast-like' cells are the cellular source of capsular collagen in hepatocellular carcinoma. Journal of Hepatology, 26 (4), 798-807. doi: 10.1016/S0168-8278(97)80245-0 |
|
1997 Journal Article Hepatic stellate cell activation in genetic haemochromatosis - Lobular distribution, effect of increasing hepatic iron and response to phlebotomyRamm, G. A., Crawford, D. H. G., Powell, L. W., Walker, N. I., Fletcher, L. M. and Halliday, J. W. (1997). Hepatic stellate cell activation in genetic haemochromatosis - Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. Journal of Hepatology, 26 (3), 584-592. doi: 10.1016/S0168-8278(97)80424-2 |
|
1997 Conference Publication In vivo hepatic activities of matrix metalloproteinases-2, 3 and 9 are increased in prefibrotic animal and human iron overloadGeorge, D.K., Ramm, G.A., Bridle, K.R., Fletcher, L.M. and Crawford, D.H.G. (1997). In vivo hepatic activities of matrix metalloproteinases-2, 3 and 9 are increased in prefibrotic animal and human iron overload. 48th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 7-11 November 1997. Hoboken, NJ, United States: John Wiley & Sons. |
|
1997 Conference Publication Interferon-gamma but not transforming growth factor-beta gene expression is upregulated in liver tissue of patients with genetic hemochromatosisBridle, K.R., Crawford, D.H.G., Fletcher, L.M. and Ramm, G.A. (1997). Interferon-gamma but not transforming growth factor-beta gene expression is upregulated in liver tissue of patients with genetic hemochromatosis. 48th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 7-11 November 1997. Hoboken, NJ, United States: John Wiley & Sons. |
|
1997 Conference Publication Contribution of parenchymal and non-parenchymal cells to hepatic fibrogenesis in biliary atresiaRamm, G.A., Shepherd, R.W. and Crawford, D.H.G. (1997). Contribution of parenchymal and non-parenchymal cells to hepatic fibrogenesis in biliary atresia. 48th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 7-11 November 1997. Hoboken, NJ, United States: John Wiley & Sons. |
|
1997 Conference Publication The role of activated hepatic stellate cells in capsule formation in hepatocellular carcinoma and colorectal metastases to the liverRamm, G.A., Ooi, L. L. P. J., Gotley, D. C., Clouston, A. D., Bridle, K. R. and Crawford, D. H. G. (1997). The role of activated hepatic stellate cells in capsule formation in hepatocellular carcinoma and colorectal metastases to the liver. 8th International Symposium on the Cells of the Hepatic Sinusoid, Bordeaux, France, 1-5 September 1996. Leiden, Netherlands: Kupffer Cell Foundation. |
|
1997 Conference Publication Role of tissue ferritin in regulation of alpha-smooth muscle actin expression in hepatic stellate cells via PKC zeta and/or nitric oxideRamm, G.A., Piva, T.J., Garrone, B.M., Watters, D.J. and Crawford, D.H.G. (1997). Role of tissue ferritin in regulation of alpha-smooth muscle actin expression in hepatic stellate cells via PKC zeta and/or nitric oxide. 48th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 7-11 November 1997. Hoboken, NJ, United States: John Wiley & Sons. |
